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Propositions 
 
1. Exposure schedules for tanning need not be adjusted for skin type since higher skin 
types tan more efficiently than lower skin types (this thesis, chapter 4). 
2. The monochromatic action spectrum for tanning (Parrish, J.A., K.F. Jaenicke, and R. 
R. Anderson, Erythema and melanogenesis action spectra of normal human skin. 
Photochem. Photobiol. 1982: 36: 187-191) does not properly predict tanning efficacy 
of repeated exposures to sunbeds (this thesis, chapter 3). 
3. A similar degree of tanning is more quickly attained with a UVA-enriched sunbed 
(e.g. 98% vs 95% UVA) with a lower cumulative CIE erythemal or carcinogenic 
dose, and therefore less risk of squamous cell carcinomas (this thesis, chapter 3).  
4. The pigmentation system in human skin saturates after a total of approximately 29 
Standard Erythemal Doses (SEDs), (this thesis, chapter 2 and 3). Tanning salon 
operators should, therefore, provide skin color measurement services, enabling 
customers to see that their pigmentation is at the maximum level and their tanning 
course is completed. 
5. Administering UV exposures 2x/week vs. 3x/week after the first week allows for 
development of a visually equivalent tan with 2 to 3 times lower cumulative dose. 
(this thesis, chapter 3) 
6. For typical tanners (20 exposures/yr  @ 4 SED/exposure) the total annual UVA dose 
from common sunlamps is 0.3 to 1.2 times that from the sun and 2.9 times for high 
pressure UVA sunlamps (Miller SA, Hamilton SL, Wester UG, Cyr HW, Photochem 
Photobiol 1998; 68(1): 63-70). For frequent tanners (100 exposures/yr @ 8 
SED/exposure), the total annual UVA dose from common sunlamps is 1.2 to 4.7 times 
that from the sun and 12 times for high pressure UVA sunlamps. If UVA exposure is 
found to be important in the etiology of melanoma, this should have ramifications for 
regulatory restrictions on high UVA-emitting sunlamps. 
7. Lazovich et al.  (Canc Epid Biom Prev 2010; 19: 1557-1568) reported that as the 
number of lifetime sunbed exposures increases, so does the risk of melanoma in 
subjects 25 to 59 years of age.  Interestingly, this appears to be contrary to evidence 
showing that outdoor workers do not have an increased risk of melanoma compared to 
indoor workers. As indoor tanners typically expose their whole body to UV radiation 
while the body of outdoor workers is likely covered (for the most part) by clothing, 
this paradox indicates that a systemic effect may be involved. 
8. The historically-used Fitzpatrick questionnaire for skin phototyping could be 
improved for the assessment of UV sensitivity by limiting the classification to 
questions about sunburn responses only, thus avoiding ambiguities which may arise 
from including questions about ability to tan (CIE 207: 2014 “Sensitivity of Human 
Skin to Ultraviolet Radiation, Expressed as Minimal Erythema Dose (MED)”).  
9. Based on exposures from two ‘solar simulators’ with different dose rates, it appears 
that the higher dose rate produced significantly more sunburn cells for the same dose. 
Therefore, lower dose-rate sunlamps are not necessarily ‘safer’ than higher dose-rate 
sunlamps, contrary to current thinking by many regulatory authorities (the 
International (IEC 60335-2-27) and European (EN 60335-2-27) standards both 
require limits on the dose rates of sunlamps/tanning beds). 
10. There is a clear dose-response trend between duration of cataract surgery and 
subsequent risk of retinal photic maculopathy [Byrnes GA et al. “Prospective 
Incidence of Photic Maculopathy after Cataract Surgery” AJO 119:92, 1995]. 
Corresponding retinal blue-light dosages for a visual lesion need to be corrected for 
beam interruptions for comparison with and improvement of the current exposure 
limit. Thus, the blue-light hazard to the human retina, e.g. from light-emitting 
ophthalmic instruments, could be better assessed. 
11. The critical wavelength method [Diffey BL, Tanner PR, Matts PJ, Nash JF; JAAD 
2000; 43(6): 1024-35] for evaluating the UVA absorbance of sunscreens, although 
indicative of short wavelength UVA absorbance, lacks biological relevance. Concerns 
about health effects of UVA need to be substantiated by proper action spectra.  
12. Until ‘Citizen’s United’ - the case that overturned the ban on corporate expenditures 
for political candidates [http://cacs.org/research/citizens-united/#two] - is reversed by 
the US Supreme Court, the democratic form of US government is in serious jeopardy.  
13. The FDA should ban ‘Direct-to-Consumer’ advertising of pharmaceuticals, on which 
spending has increased by 30 % in the last 2 years to $4.5 billion. This excessive 
spending leads to increased costs for consumers, yet does nothing to improve the 
health of consumers. [http://www.fiercepharmamarketing.com/story/pharmas-ad-
spend-vaults-45b-big-spender-pfizer-leading-way/2015-03-25] 
 
